Key result
Flecainide suppresses regular VT in a patient with TECRL-CPVT presenting with cardiac arrest.
Why the study?
Does flecainide suppress arrhythmia in a patient with TECRL-CPVT?
Case Report (n=1)
Does flecainide suppress arrhythmia in a patient with TECRL-CPVT?
Flecainide may be effective in suppressing ventricular arrhythmias in patients with TECRL-related CPVT.
INTRODUCTION: We describe a unique case of TECRL-CPVT presented with cardiac arrest. METHODS: Post resuscitation, the patient developed regular ventricular tachycardia featuring a left purkinje system morphology. RESULTS: There was clear suppression of arrhythmia with the addition of flecainide and isolated ventricular ectopy causing secondary T-wave changes. CONCLUSION: A high index of suspicion was required to eventually make the diagnosis through whole exome sequencing.
No takes yet. Share an insight, caveat, or question.
Ebrahim et al. (2023) conducted a case report in TECRL-CPVT (n=1). Flecainide was evaluated on Suppression of arrhythmia. Flecainide successfully suppressed regular ventricular tachycardia in a patient with TECRL-CPVT who presented with cardiac arrest.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: